Foghorn Therapeutics Inc.
FHTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $55 | $80 | $52 | $101 |
| Short-Term Investments | $188 | $154 | $294 | $53 |
| Receivables | $0 | $0 | $0 | $300 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $6 | $6 | $6 | $5 |
| Total Curr. Assets | $250 | $240 | $351 | $460 |
| Property Plant & Equip (Net) | $33 | $43 | $49 | $56 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $3 | $4 | $4 |
| Total NC Assets | $34 | $46 | $53 | $60 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $284 | $286 | $405 | $520 |
| Liabilities | – | – | – | – |
| Payables | $4 | $6 | $5 | $4 |
| Short-Term Debt | $9 | $9 | $6 | $7 |
| Tax Payable | $0 | $1 | $0 | $0 |
| Deferred Revenue | $46 | $35 | $33 | $28 |
| Other Curr. Liab. | $9 | $8 | $11 | $10 |
| Total Curr. Liab. | $67 | $58 | $55 | $49 |
| LT Debt | $28 | $37 | $46 | $51 |
| Deferred Rev, NC | $234 | $268 | $304 | $323 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $263 | $305 | $350 | $374 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $37 | $45 | $52 | $58 |
| Total Liabilities | $330 | $363 | $405 | $423 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$558 | -$472 | -$373 | -$264 |
| AOCI | $0 | -$1 | -$4 | -$0 |
| Other Equity | $513 | $395 | $377 | $361 |
| Total Equity | -$46 | -$77 | $0 | $97 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $284 | $286 | $405 | $520 |
| Net Debt | -$18 | -$35 | -$1 | -$43 |